NCT02110459

Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment

An Open-label, Non-randomized, Monocenter, Single-dose, Phase I Study to Evaluate Pharmacokinetics and Safety of POL7080 Administered as Single Intravenous Infusion to Subjects With Renal Impairment

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Polyphor Ltd. · Industry
• Sex: All
• Age: 18 Years – 79 Years
• Healthy volunteers: Accepted

Summary

To investigate the pharmacokinetics (PK) of POL7080 in subjects with renal function impairment after single intravenous (IV) infusion of POL7080

Conditions

• Renal Impairment

Interventions

Type	Name	Description
DRUG	POL7080	Intravenous infusion

Timeline

• Start date: 2013-04-01
• Primary completion: 2015-07-01
• Completion: 2015-07-01
• First posted: 2014-04-10
• Last updated: 2016-06-17

Locations

1 site across 1 country: Germany